Golden Helix customers continue to push the boundaries of genomic research and clinical applications, leveraging VarSeq to analyze complex genetic data and uncover previously uncatalogued variants. With advancements in long-read sequencing and our recent updates to the VarSeq software, clinicians can now harness phasing information to distinguish between inherited and novel mutations in a Trio analysis with unprecedented accuracy. In... Read more »The post Bringing Phasing Information from Long-Read Data into a Trio Analysis appeared first on The Golden Helix Blog.